Greenwich LifeSciences In... (GLSI)
NASDAQ: GLSI
· Real-Time Price · USD
10.91
0.26 (2.44%)
At close: Oct 03, 2025, 3:59 PM
10.66
-2.29%
After-hours: Oct 03, 2025, 04:10 PM EDT
2.44% (1D)
| Bid | 10.55 |
| Market Cap | 148.71M |
| Revenue (ttm) | 3.61K |
| Net Income (ttm) | -17.99M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -7.96 |
| Forward PE | -7.2 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 11.25 |
| Volume | 45,614 |
| Avg. Volume (20D) | 69,761 |
| Open | 10.76 |
| Previous Close | 10.65 |
| Day's Range | 10.76 - 11.13 |
| 52-Week Range | 8.06 - 15.47 |
| Beta | 3.10 |
| Ex-Dividend Date | n/a |
About GLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+3.55%
Greenwich LifeSciences shares are trading higher a...
Unlock content with
Pro Subscription
6 months ago
+0.97%
Greenwich LifeSciences shares are trading higher after the company announced immune response data from its FLAMINGO-01 Phase 3 clinical trial.
